Sacco, J. J., Moser, J. C., Warner, A. B., Sullivan, R. J., Davar, D., Shoushtari, A. N., Carvajal, R. D., Patel, S. P., Joshua, A. M., Hassel, J. C., Navarro, M., Marpadga, R., Gullo, G., Orloff, M. M. (2025). A randomized, phase 2/3 clinical trial investigating RP2 plus nivolumab vs ipilimumab plus nivolumab in immune checkpoint inhibitor-naïve patients with metastatic uveal melanoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps9597